CC
USNA icon

Cypress Capital’s Usana Health Sciences USNA Stock Holding History

Cypress Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,444
Closed -$205K – 97
2025
Q3 		$205K Sell
7,444
-75
-1% -$2.31K 0.06% 90
2025
Q2 		$230K Sell
7,519
-233
-3% -$6.62K 0.07% 84
2025
Q1 		$209K Sell
7,752
-510
-6% -$16.1K 0.06% 77
2024
Q4 		$297K Sell
8,262
-834
-9% -$31.2K 0.08% 66
2024
Q3 		$345K Sell
9,096
-338
-4% -$13.9K 0.09% 70
2024
Q2 		$427K Sell
9,434
-992
-10% -$45.6K 0.11% 71
2024
Q1 		$506K Buy
10,426
+208
+2% +$10.2K 0.14% 59
2023
Q4 		$548K Sell
10,218
-421
-4% -$21.3K 0.16% 56
2023
Q3 		$624K Sell
10,639
-1,609
-13% -$101K 0.18% 54
2023
Q2 		$772K Buy
12,248
+21
+0.2% +$1.34K 0.22% 55
2023
Q1 		$769K Sell
12,227
-358
-3% -$21.4K 0.24% 47
2022
Q4 		$670K Sell
12,585
-46
-0.4% -$2.49K 0.21% 61
2022
Q3 		$708K Sell
12,631
-871
-6% -$57.6K 0.25% 61
2022
Q2 		$977K Sell
13,502
-175
-1% -$13K 0.14% 108
2022
Q1 		$1.09M Buy
13,677
+1,290
+10% +$116K 0.13% 113
2021
Q4 		$1.25M Sell
12,387
-1,734
-12% -$173K 0.14% 113
2021
Q3 		$1.3M Buy
14,121
+250
+2% +$24.1K 0.17% 102
2021
Q2 		$1.42M Sell
13,871
-100
-0.7% -$10K 1.39% 36
2021
Q1 		$1.36M Sell
13,971
-223
-2% -$20.3K 0.56% 36
2020
Q4 		$1.09M Sell
14,194
-219
-2% -$16.9K 0.5% 43
2020
Q3 		$1.13M Sell
14,413
-622
-4% -$49.9K 0.52% 37
2020
Q2 		$1.1M Buy
+15,035
New +$1.18M 0.49% 37
2019
Q4 		$1.33M Sell
16,876
-926
-5% -$68.2K 0.56% 26
2019
Q3 		$1.22M Sell
17,802
-1,679
-9% -$113K 0.56% 24
2019
Q2 		$1.55M Sell
19,481
-2,623
-12% -$208K 0.7% 20
2019
Q1 		$1.85M Sell
22,104
-2,736
-11% -$286K 0.77% 18
2018
Q4 		$2.92M Buy
+24,840
New +$2.87M 1.34% 13

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cypress Capital's USNA Position: Q4 2025 in Review

Cypress Capital sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 7,444 shares — an estimated $205K sold.

Cypress Capital first reported a position in USNA in Q4 2018 and held it in 27 quarters. The position peaked at $2.92M in Q4 2018. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Cypress Capital reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Cypress Capital sold 7,444 Usana Health Sciences shares in Q4 2025, an estimated $205K.
  • Cypress Capital first reported a position in Usana Health Sciences in Q4 2018 and held it in 27 quarters.
  • Cypress Capital's Usana Health Sciences position peaked at $2.92M in Q4 2018.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Cypress Capital's 13F filing for Q4 2025, filed 6 Feb 2026.